[1]黄红梅,李 婷,李 英,等.甲基莲心碱对糖尿病肾病大鼠肾脏氧化应激的影响[J].医学信息,2025,38(07):92-95.[doi:10.3969/j.issn.1006-1959.2025.07.016]
 HUANG Hongmei,LI Ting,LI Ying,et al.Effect of Neferine on Oxidative Stress in Kidney of Diabetic Nephropathy Rats[J].Journal of Medical Information,2025,38(07):92-95.[doi:10.3969/j.issn.1006-1959.2025.07.016]
点击复制

甲基莲心碱对糖尿病肾病大鼠肾脏氧化应激的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年07期
页码:
92-95
栏目:
论著
出版日期:
2025-04-01

文章信息/Info

Title:
Effect of Neferine on Oxidative Stress in Kidney of Diabetic Nephropathy Rats
文章编号:
1006-1959(2025)07-0092-04
作者:
黄红梅1李 婷1李 英1袁 璐1古 诗1徐 勇2
1.成都市双流区第一人民医院内分泌科,四川 成都 610200;2.西南医学大学附属医院内分泌科,四川 泸州 646099
Author(s):
HUANG Hongmei1 LI Ting1 LI Ying1 YUAN Lu1 GU Shi1 XU Yong2
1.Department of Endocrinology, the First People’s Hospital of Shuangliu District, Chengdu 610200, Sichuan, China;2.Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou 646099, Sichuan, China
关键词:
甲基莲心碱糖尿病肾病氧化应激
Keywords:
Neferine Diabetic nephropathy Oxidative stress
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2025.07.016
文献标志码:
A
摘要:
目的 探究甲基莲心碱对糖尿病肾病大鼠肾脏氧化应激的影响。方法 将SD雄性大鼠随机分为对照组、模型组、治疗组和阳性对照组。除对照组外,其余三组予以高糖高脂饲料喂养制造DN模型。造模成功以后分组药物治疗。对照组和模型组使用等量盐水灌胃,治疗组使用40 mg/kg甲基莲心碱灌胃,阳性对照组使用厄贝沙坦14 mg/kg灌胃。HE染色光学显微镜下观察大鼠肾脏组织病理情况,生化分析大鼠尿液尿蛋白含量,ELISA检测大鼠肾脏组织TNF-α、SOD和MDA含量。结果 与对照组相比,模型组肾脏组织结构受损明显,大鼠尿液尿蛋白显著增加,肾组织SOD含量显著下降,MDA和TNF-α含量显著上升(P<0.01);与模型组相比,治疗组局部肾脏组织不同程度受损,治疗组尿蛋白显著减少(P<0.01),SOD含量上升(P<0.05),MDA和TNF-α含量下降(P<0.05)。结论 甲基莲心碱可改善糖尿病肾病大鼠肾脏组织损伤,降低尿蛋白含量,缓解氧化应激水平和炎症反应。
Abstract:
Objective To investigate the effect of neferine on renal oxidative stress in rats with diabetic nephropathy. Methods SD male rats were randomly divided into control group, model group, treatment group and positive control group. In addition to the control group, the other three groups were fed with high-sugar and high-fat diet to make DN model. After successful modeling, grouped drug treatment. The control group and the model group were intragastrically administered with the same amount of saline, the treatment group was intragastrically administered with 40 mg/kg neferine, and the positive control group was intragastrically administered with 14 mg/kg irbesartan. HE staining was used to observe the pathological conditions of rat kidney tissue under optical microscope. Biochemical analysis of urinary protein content in rats was performed. ELISA was used to detect the contents of TNF-α, SOD and MDA in rat kidney tissue. Results Compared with the control group, the renal tissue structure of the model group was significantly damaged, the urine protein of rats was significantly increased, the content of SOD in renal tissue was significantly decreased, and the contents of MDA and TNF-α were significantly increased (P<0.01). Compared with the model group, the local renal tissue of the treatment group was damaged to varying degrees, the urine protein of the treatment group was significantly reduced (P<0.01), the content of SOD was increased (P<0.05), and the content of MDA and TNF-α was decreased in the treatment group(P<0.05). Conclusion Neferine can improve the damage of renal tissue in diabetic nephropathy rats, reduce the content of urinary protein, and alleviate the oxidative stress level and inflammatory response in the kidney group of diabetic nephropathy rats.

参考文献/References:

[1]Jiang G,Luk AO,Tam CHT,et al.Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes[J].Diabetes,2022,71(3):520-529.[2]Lei Q,Xu F,Liang S,et al.Clinical Acute Kidney Injury and Histologic Acute Tubular-Interstitial Injury and Their Prognosis in Diabetic Nephropathy [J].Nephron,2022,146(4):351-359.[3]Bu L,Dai O,Zhou F,et al.Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis[J].Biomed Pharmacother,2020,132:110855.[4]樊思轩,舒丽莎,任美颖.基于PI3K/Akt信号通路探讨甲基莲心碱对HeLa细胞的影响[J].中成药,2023,45(7):2185-2192.[5]庄葛,吴霞,石帅.温胆汤加减联合高通量血透对糖尿病肾病的抗氧化及抗微炎症作用观察[J].中国中西医结合肾病杂志,2019,20(2):163-165. [6]Samsu N.Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment[J].Biomed Res Int,2021,2021:1497449.[7]Jin Q,Liu T,Qiao Y,et al.Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols[J].Front Immunol,2023,14:1185317.[8]Qi C,Mao X,Zhang Z,et al.Classification and Differential Diagnosis of Diabetic Nephropathy[J].J Diabetes Res,2017,2017:8637138.[9]Ceccarelli Ceccarelli D,Paleari R,Solerte B,et al.Re-thinking diabetic nephropathy: Microalbuminuria is just a piece of the diagnostic puzzle[J].Clin Chim Acta,2022,524:146-153.[10]Thakur SK,Dhakal SP,Parajuli S,et al.Microalbuminuria and Its Risk Factors in Type 2 Diabetic Patients[J].J Nepal Health Res Counc,2019,17(1):61-65.[11]Xiong Y,Zhu W,Xu Q,et al.Sleeve Gastrectomy Attenuates Diabetic Nephropathy by Upregulating Nephrin Expressions in Diabetic Obese Rats[J].Obesity Surgery,2020,30(8):2893-2904.[12]Sagoo MK,Gnudi L.Diabetic Nephropathy: An Overview[J].Methods in Molecular Biology (Clifton,NJ),2020,2067:3-7.[13]Fu Y,Sun Y,Wang M,et al.Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism [J].Cell Metabolism,2020,32(6):1052-1062.e8.[14]王瑞瑞,姜国清.血清GSH-PX、MDA及eNOS对2型糖尿病患者胰岛素抵抗的诊断意义[J].吉林医学,2023,44(11):3095-3097.[15]郑伟,海军,宋晓雪,等.甲基莲心碱对肝缺血再灌注损伤模型小鼠氧化应激和炎症反应的影响[J].中国药房,2018,29(15):2068-2072. [16]Calle P,Hotter G.Macrophage Phenotype and Fibrosis in Diabetic Nephropathy[J].Int J Mol Sci,2020,21(8):2806.[17]Chang WW,Liang W,Yao XM,et al.Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy[J].J Renin Angiotensin Aldosterone Syst,2018,19(3):1470320318785744.[18]Campolo M,Paterniti I,Siracusa R,et al.TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model[J].Brain Behav Immun,2019,76:236-247.[19]Hou L,Sun F,Sun W,et al.Lesion of the Locus Coeruleus Damages Learning and Memory Performance in Paraquat and Maneb-induced Mouse Parkinson’s Disease Model[J].Neuroscience,2019,419:129-140.[20]Somensi N,Lopes SC,Gasparotto J,et al.Role of toll-like receptor 4 and sex in 6-hydroxydopamine-induced behavioral impairments and neurodegeneration in mice[J].Neurochem Int,2021,151:105215.

相似文献/References:

[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
 CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(07):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
 HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Journal of Medical Information,2018,31(07):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
 HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
 HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者 血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
 LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
 ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
 LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Journal of Medical Information,2018,31(07):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[8]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
 XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Journal of Medical Information,2019,32(07):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[9]张国艳,张佳田,隋洪玉.糖尿病肾病大鼠动物模型建立及INF-α干预机制研究[J].医学信息,2019,32(05):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
 ZHANG Guo-yan,ZHANG Jia-tian,SUI Hong-yu.Establishment of Animal Model of Diabetic Nephropathy Rats and Study of INF-α Intervention Mechanism[J].Journal of Medical Information,2019,32(07):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
[10]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
 WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Journal of Medical Information,2019,32(07):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]

更新日期/Last Update: 1900-01-01